NBEV

NewAge, Inc. [NBEV] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NBEV Stock Summary

In the News

08:25 28 Mar 2024 NBEV

Former CEO of NewAge, a drink company that shot to pot-stock fame, accused by SEC of ‘multi-year fraud'

The Securities and Exchange Commission has filed charges against former NewAge Inc. Chief Executive Brent David Willis, accusing him of a “multi-year fraud” that included misleading public statements meant to promote the wellness-focused beverage maker that once hoped to take advantage of the nation's CBD craze.

06:00 28 Mar 2024 NBEV

7 Penny Stocks That Actually Have a Buy Rating

Finding penny stocks with buy ratings is becoming increasingly difficult. The higher interest rates go, the more risk-averse the markets become.

06:00 28 Mar 2024 NBEV

Hot Penny Stocks to Buy After the Long Weekend? 3 to Watch

Which penny stocks are on your watchlist today? The post Hot Penny Stocks to Buy After the Long Weekend?

11:30 28 Mar 2024 NBEV

Which Strategies Are You Using With Penny Stocks in September?

Are you using these strategies for trading penny stocks right now? The post Which Strategies Are You Using With Penny Stocks in September?

10:28 28 Mar 2024 NBEV

7 Penny Stocks to Sell Before They Go to Zero

The first half of 2022 for the stock market was the worst since 1970. Consequently, investors are forced to re-evaluate their portfolios and discard risky assets.

06:00 28 Mar 2024 NBEV

Trending Penny Stocks to Buy in September? 3 For Your List

Which penny stocks are you watching today? The post Trending Penny Stocks to Buy in September?

07:52 28 Mar 2024 NBEV

New Age: Four Catalysts That We Like Including A Valuation That Is  Too Cheap To Ignore

Once high-flying New Age has had its wings clipped and continues to suffer a hangover from the disasterous Brent Willis era. With Willis now gone, Interim CEO John Brennan is attempting to breathe new life into the company and has taken steps in an effort to increase shareholder value.

04:05 28 Mar 2024 NBEV

NewAge, Inc. Delays Fourth Quarter and Full Year 2021 Financial Results Conference Call

SALT LAKE CITY, March 15, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV), a direct selling company with a primary focus on healthy products, today announced its fourth quarter and full year 2021 earnings release and conference call will be rescheduled to allow additional time to complete its Annual Report on Form 10-K. The Company will be filing a Form 12b-25, Notification of Late Filing, on March 16, 2022, which will provide the Company with a 15-day extension to file its Form 10-K. The Company expects to report financial results for the quarter and full year ended December 31, 2021, on or before March 31, 2022, the expiration date of the extension period. Updated conference call details will be provided in a subsequent announcement.

06:17 28 Mar 2024 NBEV

NewAge to weigh reverse stock split to regain Nasdaq listing requirement

NewAge Inc. NBEV, -0.14% said Friday it has received notice from Nasdaq Stock Market LLC that it is not in compliance with the $1.00 closing bid listing requirement. The Utah-based health and wellness beverage and cannabis company has 180 days, until Aug. 23, to regain compliance or its stock will be delisted.

06:05 28 Mar 2024 NBEV

NewAge, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 16

SALT LAKE CITY, Feb. 25, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV), a direct-to-consumer (D2C) healthy products company, today announced that it will release financial results for its fourth quarter and full year ended December 31, 2021, after the market close on Wednesday, March 16, 2022.

NBEV Financial details

Company Rating
Neutral
Market Cap
0
Income
-3.1M
Revenue
439.53M
Book val./share
1.47
Cash/share
0.31
Dividend
-
Dividend %
-
Employees
1.09K
Optionable
Yes
Shortable
Yes
Earnings
16 Sep 2022
P/E
-0.23
Forward P/E
-
PEG
0.02
P/S
-
P/B
0.06
P/C
-
P/FCF
-
Quick Ratio
0.46
Current Ratio
1.04
Debt / Equity
0.32
LT Debt / Equity
0.19
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-64.66%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
16.63%
Revenue last 5Y
61.67%
Revenue Q/Q
-19.74%
EPS Q/Q
-114.83%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
22.64%
Inst Trans
1.05%
ROA
-10%
ROE
-33%
ROC
-0.14%
Gross Margin
64%
Oper. Margin
-12%
Profit Margin
-14%
Payout
-
Shs Outstand
146.81M
Shs Float
130.49M
-
-
-
-
Target Price
-
52W Range
0.0912-0.1121
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.54128
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

NBEV Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2020-12-31

Metric History 2016-12-312017-12-312018-12-312019-12-31 2020-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.341.71.123.282.9
Net income per share
-0.19-0.12-0.26-1.16-0.41
Operating cash flow per share
0.05-0.27-0.47-0.41-0.36
Free cash flow per share
0.05-0.29-0.49-0.5-0.38
Cash per share
0.030.010.920.790.45
Book value per share
0.261.723.331.191.5
Tangible book value per share
-0.240.261.190.5-1.49
Share holders equity per share
0.261.723.331.191.5
Interest debt per share
0.810.120.120.360.38
Market cap
73.29M66.44M241.53M140.6M253.4M
Enterprise value
87.73M73.64M203.71M103.77M243.88M
P/E ratio
-20.17-18.79-19.9-1.57-6.44
Price to sales ratio
2.91.274.630.550.91
POCF ratio
75.16-7.9-11.06-4.42-7.4
PFCF ratio
78.98-7.4-10.7-3.61-6.9
P/B Ratio
15.021.261.561.521.76
PTB ratio
15.021.261.561.521.76
EV to sales
3.471.413.910.410.87
Enterprise value over EBITDA
-31.22-43.28-11.52-1.61-8.15
EV to operating cash flow
89.96-8.76-9.33-3.26-7.12
EV to free cash flow
94.54-8.21-9.02-2.66-6.64
Earnings yield
-0.05-0.05-0.05-0.64-0.16
Free cash flow yield
0.01-0.14-0.09-0.28-0.14
Debt to equity
3.070.060.030.260.24
Debt to assets
0.560.050.020.10.09
Net debt to EBITDA
-5.14-4.232.140.570.32
Current ratio
0.871.461.741.421.04
Interest coverage
-12.13-26.53-18.14-20.49-14.63
Income quality
-0.272.381.80.350.87
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.310.280.3900.41
Research and developement to revenue
00000
Intangibles to total assets
0.350.660.350.210.59
Capex to operating cash flow
-0.050.070.030.230.07
Capex to revenue
0-0.01-0.01-0.03-0.01
Capex to depreciation
-0.09-0.35-0.32-0.82-0.28
Stock based compensation to revenue
00.030.050.030.02
Graham number
1.062.124.425.593.71
ROIC
-0.2-0.18-0.06-0.59-0.15
Return on tangible assets
-0.21-0.15-0.06-0.46-0.25
Graham Net
-0.82-0.18-1.36-0.92-2.3
Working capital
-1.44M5.11M40.91M33.53M4.59M
Tangible asset value
-4.56M7.95M55.19M38.55M-143.72M
Net current asset value
-11.84M1.29M-36.42M-45.9M-171.79M
Invested capital
3.070.060.030.260.24
Average receivables
2.49M6.1M9.22M11.06M11.74M
Average payables
3.58M5.63M6.67M11.11M18.02M
Average inventory
2.31M5.73M22.09M36.93M42.38M
Days sales outstanding
68.2252.1976.8416.0216.12
Days payables outstanding
128.7540.0976.347.9281.51
Days of inventory on hand
82.7264.6316.32132.69171.98
Receivables turnover
5.356.994.7522.7922.65
Payables turnover
2.839.14.787.624.48
Inventory turnover
4.415.651.152.752.12
ROE
-0.74-0.07-0.08-0.97-0.27
Capex per share
0-0.02-0.02-0.09-0.03

Quarterly Fundamentals Overview

Last date of statement is 2021-09-30 for Q3

Metric History 2020-09-302020-12-312021-03-312021-06-30 2021-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.640.920.990.860.66
Net income per share
-0.140-0.140.12-0.02
Operating cash flow per share
-0.06-0.04-0.02-0.02-0.13
Free cash flow per share
-0.07-0.05-0.02-0.03-0.14
Cash per share
0.270.450.710.560.31
Book value per share
0.861.471.321.551.47
Tangible book value per share
0.35-1.47-0.410.020.15
Share holders equity per share
0.861.471.321.551.47
Interest debt per share
0.210.360.590.580.48
Market cap
169.23M257.26M363.96M320.31M210.46M
Enterprise value
162.31M247.75M345.12M319.56M233.99M
P/E ratio
-2.99-15.92K-5.124.61-19.49
Price to sales ratio
2.72.852.92.582.11
POCF ratio
-27.05-58.5-169.99-93.68-10.5
PFCF ratio
-26.5-54.04-149.9-82.19-10.24
P/B Ratio
2.011.782.161.440.95
PTB ratio
2.011.782.161.440.95
EV to sales
2.592.742.752.582.35
Enterprise value over EBITDA
-14.561.1K-41.2412.2849.87
EV to operating cash flow
-25.94-56.33-161.19-93.47-11.67
EV to free cash flow
-25.42-52.04-142.14-82-11.38
Earnings yield
-0.080-0.050.05-0.01
Free cash flow yield
-0.04-0.02-0.01-0.01-0.1
Debt to equity
0.240.240.430.360.32
Debt to assets
0.090.090.150.180.17
Net debt to EBITDA
0.62-42.12.25-0.035.02
Current ratio
1.411.041.431.51.42
Interest coverage
-25.23-3.72-1.02-3.11-12.05
Income quality
0.441.09K0.12-0.27.43
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
01.25000
Research and developement to revenue
00000
Intangibles to total assets
0.230.590.470.480.49
Capex to operating cash flow
0.020.080.130.140.03
Capex to revenue
0000-0.01
Capex to depreciation
-0.07-0.11-0.06-0.1-0.11
Stock based compensation to revenue
0.020.010.020.020.01
Graham number
1.670.042.042.050.77
ROIC
-0.110.92-0.01-0.03-0.1
Return on tangible assets
-0.080-0.070.07-0.01
Graham Net
-0.87-2.27-1.38-0.83-0.7
Working capital
21.29M4.59M47.2M53.95M40.78M
Tangible asset value
33.99M-143.72M-52.68M3.23M22.95M
Net current asset value
-61.91M-171.79M-140.26M-68.5M-44.96M
Invested capital
0.240.240.430.360.32
Average receivables
11.76M11.34M12.26M11.33M9.67M
Average payables
11.65M16.69M19.54M16.71M17.55M
Average inventory
32.27M39.31M45.5M43.58M46.55M
Days sales outstanding
14.8312.288.747.68.02
Days payables outstanding
37.8168.2538.5138.2748.25
Days of inventory on hand
109.06144.01101.498.9131.05
Receivables turnover
6.077.3310.311.8511.22
Payables turnover
2.381.322.342.351.87
Inventory turnover
0.830.620.890.910.69
ROE
-0.170-0.110.08-0.01
Capex per share
00000

NBEV Frequently Asked Questions

What is NewAge, Inc. stock symbol ?

NewAge, Inc. is a US stock , located in Denver of Colorado and trading under the symbol NBEV

What is NewAge, Inc. stock quote today ?

NewAge, Inc. stock price is $- today.

Is NewAge, Inc. stock public?

Yes, NewAge, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap